CEACAM5 and neoplasm: Some studies have described that clinicopathological features such as tumor size, the carcinoembryonic antigen (CEA) level, adjuvant chemotherapy, and the log odds of metastatic lymph nodes (LODDS) may also influence colon cancer patients’ survival outcomes [5, 6].